Posted inInternational FDA Orders New Vision Warnings for Popular GLP-1 Weight-Loss Medications Federal regulators require updated safety labels on GLP-1 drugs like Ozempic and Wegovy to warn patients about a rare eye condition called NAION. Posted by srkanalytics.srk@gmail.com November 11, 2026
